Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 3/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | CDK2 | P24941 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6992749 | 0.72 | CYP2A6 (0.38) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL6581783 | 0.72 | GPR3 (0.31) | GPR3 | |
| SCHEMBL2490828 | 0.71 | CHRM2 (0.50) | MIFCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL2965431 | 0.66 | ALDH1A1 (0.33) | GPR3ALDH1A1 | |
| SCHEMBL1310425 | 0.64 | PIN1 (0.56) | MIFCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL10325069 | 0.62 | PIN1 (0.42) | MIFCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7852353 | 0.62 | MAOB (0.46) | MIFCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7507706 | 0.61 | MIF (0.46) | MIFCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL10325067 | 0.61 | MAOB (0.40) | MIFCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL5987950 | 0.61 | KDM4E (0.42) | ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11999754-B2 | Ruthenium complexes and their use in olefin metathesis reactions | APEIRON SYNTHESIS S.A. (PL) | 2024-06-04 | — | — | US | disclosed |
| US-11976085-B2 | Process for producing ruthenium complexes and intermediates thereof and their use in olefin metathesis | Aperion Synthesis S.A. (PL) | 2024-05-07 | — | — | US | disclosed |
| WO-2024052871-A1 | NOVEL RUTHENIUM COMPLEXES, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USED IN THIS METHOD, METHOD OF THEIR SYNTHESIS AND USE OF NOVEL RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | UNIWERSYTET WARSZAWSKI (PL) | 2024-03-14 | — | — | WO | disclosed |
| US-20240076308-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | APEIRON SYNTHESIS SA (PL) | 2024-03-07 | — | — | US | disclosed |
| WO-2023248205-A1 | NOVEL RUTHENIUM COMPLEXES, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS USED IN THIS METHOD, METHOD OF THEIR SYNTHESIS AND THE USE OF NOVEL RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | UNIWERSYTET WARSZAWSKI (PL) | 2023-12-28 | — | — | WO | disclosed |
| EP-4196267-B1 | NOVEL RUTHENIUM COMPLEXES, METHODS OF THEIR PREPARATION AND APPLICATION THEREOF IN OLEFIN CROSS METATHESIS | APEIRON SYNTHESIS SA (PL) | 2023-11-29 | — | — | EP | disclosed |
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | APEIRON SYNTHESIS S.A. (PL) | 2023-10-12 | — | — | US | disclosed |
| WO-2023135582-A1 | NEW STEREORETENTIVE RUTHENIUM COMPLEXES, METHOD OF THEIR PREPARATION, INTERMEDIATES USED IN THIS METHOD AND USE OF NEW STEREORETENTIVE RUTHENIUM COMPLEXES IN OLEFIN METATHESIS REACTIONS | UNIWERSYTET WARSZAWSKI (PL) | 2023-07-20 | — | — | WO | disclosed |
| US-20220177612-A1 | NEW USE OF METAL COMPLEXES HAVING ORGANIC LIGANDS FOR ACTIVATING OLEFIN METATHESIS RUTHENIUM (PRE)CATALYSTS | APEIRON SYNTHESIS SPOLKA AKCYJNA (PL) | 2022-06-09 | — | — | US | disclosed |
| US-20210380619-A1 | Production method of cyclic compounds by olefin metathesis reaction and use of ruthenium catalysts in production of cyclic olefines by olefin metathesis reaction | UNIWERSYTET WARSZAWSKI (PL) | 2021-12-09 | — | — | US | disclosed |
| US-20180298046-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | APEIRON SYNTHESIS S.A. (PL) | 2018-10-18 | — | — | US | disclosed |
| EP-3356379-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | Apeiron Synthesis S.A. (PL) | 2018-08-08 | — | — | EP | disclosed |
| WO-2018100515-A1 | NOVEL RUTHENIUM COMPLEX, METHOD OF ITS PRODUCTION AND ITS USE IN REACTION OF OLEFINE METATHESIS | UNIWERSYTET WARSZAWSKI (PL) | 2018-06-07 | — | — | WO | disclosed |
| EP-2760581-B1 | RUTHENIUM COMPLEX, METHOD FOR ITS PREPARATION AND USE THEREOF | INST CHEMII ORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) | 2016-11-09 | — | — | EP | disclosed |
| US-20150298111-A1 | Ruthenium Or Osmium Complex, Method For Its Preparation And Use Thereof | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2015-10-22 | — | — | US | disclosed |
| US-9074028-B2 | Complexes of ruthenum, method for their preparation, and their application in olefin metathesis reactions | UMICORE AG & CO. KG (DE) | 2015-07-07 | — | — | US | disclosed |
| EP-2760581-A1 | RUTHENIUM OR OSMIUM COMPLEX, METHOD FOR ITS PREPARATION AND USE THEREOF | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2014-08-06 | — | — | EP | disclosed |
| US-20140171607-A1 | New Complexes of Ruthenium, Method for Their Preparation, and Their Application in Olefin Metathesis Reactions | UMICORE AG & CO. KG (DE) | 2014-06-19 | — | — | US | disclosed |
| WO-2013046108-A1 | RUTHENIUM OR OSMIUM COMPLEX, METHOD FOR ITS PREPARATION AND USE THEREOF | Instytut Chemii Organicznej Polskiej Akademii Nauk (PL) | 2013-04-04 | — | — | WO | disclosed |
| WO-2004037247-A1 | OXINDOLES WITH ANTI-HIV ACTIVITY | IRM LLC (BM) | 2004-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150298111-A1 | Ruthenium Or Osmium Complex, Method For Its Preparation And Use Thereof | OSTC, MRPL21, AP1M1 | MIF 2433/4885CHRM2 1323/4885CHRM4 1744/4885 |
| US-20230322830-A1 | Novel ruthenium complexes, methods of their preparation and application thereof in olefin cross metathesis | CYP4F11, CYP4F3, CYP4F12 | MIF 1625/4885CHRM2 2592/4885CHRM4 1119/4885 |
| US-11976085-B2 | Process for producing ruthenium complexes and intermediates thereof and their use in olefin metathesis | POR, CYP1B1, CYP4F11 | MIF 1629/4885CHRM2 3645/4885CHRM4 2962/4885 |
| US-20140171607-A1 | New Complexes of Ruthenium, Method for Their Preparation, and Their Application in Olefin Metathesis Reactions | CYP2F1, FIS1, CYP4F11 | MIF 2257/4885CHRM2 1925/4885CHRM4 1492/4885 |
| US-20180298046-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | POR, CYP1B1, CYP4F11 | MIF 1629/4885CHRM2 3645/4885CHRM4 2962/4885 |
| US-11999754-B2 | Ruthenium complexes and their use in olefin metathesis reactions | ADH1A, CYP2E1, OPRM1 | MIF 1061/4885CHRM2 85/4885CHRM4 160/4885 |
| US-20210380619-A1 | Production method of cyclic compounds by olefin metathesis reaction and use of ruthenium catalysts in production of cyclic olefines by olefin metathesis reaction | COASY, POR, SQLE | MIF 1909/4885CHRM2 2033/4885CHRM4 1162/4885 |
| US-20240076308-A1 | PROCESS FOR PRODUCING RUTHENIUM COMPLEXES AND INTERMEDIATES THEREOF AND THEIR USE IN OLEFIN METATHESIS | POR, CYP1B1, CYP4F11 | MIF 1629/4885CHRM2 3645/4885CHRM4 2962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.